97 related articles for article (PubMed ID: 35956764)
1. MALDI-IHC-Guided In-Depth Spatial Proteomics: Targeted and Untargeted MSI Combined.
Claes BSR; Krestensen KK; Yagnik G; Grgic A; Kuik C; Lim MJ; Rothschild KJ; Vandenbosch M; Heeren RMA
Anal Chem; 2023 Jan; 95(4):2329-2338. PubMed ID: 36638208
[TBL] [Abstract][Full Text] [Related]
2. Advances in Imaging Mass Spectrometry for Biomedical and Clinical Research.
Djambazova KV; van Ardenne JM; Spraggins JM
Trends Analyt Chem; 2023 Dec; 169():. PubMed ID: 38045023
[TBL] [Abstract][Full Text] [Related]
3. Spatially resolved detection of small molecules from press-dried plant tissue using MALDI imaging.
Long ZG; Le JV; Katz BB; Lopez BG; Tenenbaum ED; Semmling B; Schmidt RJ; Grün F; Butts CT; Martin RW
Appl Plant Sci; 2023; 11(5):e11539. PubMed ID: 37915436
[TBL] [Abstract][Full Text] [Related]
4. Proteomics-Driven Biomarkers in Pancreatic Cancer.
Ramalhete L; Vigia E; Araújo R; Marques HP
Proteomes; 2023 Aug; 11(3):. PubMed ID: 37606420
[TBL] [Abstract][Full Text] [Related]
5. Characterization of Hormone Receptor and HER2 Status in Breast Cancer Using Mass Spectrometry Imaging.
Gonçalves JPL; Bollwein C; Noske A; Jacob A; Jank P; Loibl S; Nekljudova V; Fasching PA; Karn T; Marmé F; Müller V; Schem C; Sinn BV; Stickeler E; van Mackelenbergh M; Schmitt WD; Denkert C; Weichert W; Schwamborn K
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769215
[TBL] [Abstract][Full Text] [Related]
6. Advancements in Oncoproteomics Technologies: Treading toward Translation into Clinical Practice.
Punetha A; Kotiya D
Proteomes; 2023 Jan; 11(1):. PubMed ID: 36648960
[TBL] [Abstract][Full Text] [Related]
7. Application of Proteomics in Pancreatic Ductal Adenocarcinoma Biomarker Investigations: A Review.
Vellan CJ; Jayapalan JJ; Yoong BK; Abdul-Aziz A; Mat-Junit S; Subramanian P
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216204
[TBL] [Abstract][Full Text] [Related]
8. Glycoproteins and glycoproteomics in pancreatic cancer.
Pan S; Brentnall TA; Chen R
World J Gastroenterol; 2016 Nov; 22(42):9288-9299. PubMed ID: 27895417
[TBL] [Abstract][Full Text] [Related]
9. MALDI-MSI: A Powerful Approach to Understand Primary Pancreatic Ductal Adenocarcinoma and Metastases.
Gonçalves JPL; Bollwein C; Schlitter AM; Kriegsmann M; Jacob A; Weichert W; Schwamborn K
Molecules; 2022 Jul; 27(15):. PubMed ID: 35956764
[TBL] [Abstract][Full Text] [Related]
10. Development of a Class Prediction Model to Discriminate Pancreatic Ductal Adenocarcinoma from Pancreatic Neuroendocrine Tumor by MALDI Mass Spectrometry Imaging.
Casadonte R; Kriegsmann M; Perren A; Baretton G; Deininger SO; Kriegsmann K; Welsch T; Pilarsky C; Kriegsmann J
Proteomics Clin Appl; 2019 Jan; 13(1):e1800046. PubMed ID: 30548962
[TBL] [Abstract][Full Text] [Related]
11. MALDI Mass Spectrometry Imaging for the Distinction of Adenocarcinomas of the Pancreas and Biliary Tree.
Bollwein C; Gonҫalves JPL; Utpatel K; Weichert W; Schwamborn K
Molecules; 2022 May; 27(11):. PubMed ID: 35684402
[TBL] [Abstract][Full Text] [Related]
12. Proteomic Analysis of Metastasis-Specific Biomarkers in Pancreatic Cancer: Galectin-1 Plays an Important Metastatic Role in Pancreatic Cancer.
Tung CL; Lin MW; Hu RY; Chien YC; Liao EC; Lin LH; Chung TW; Wei YS; Tsai YT; Chen HY; Chou HC; Kuo WH; Ko ML; Chang SJ; Lee YR; Chan HL
J Pharm Biomed Anal; 2020 Jul; 186():113300. PubMed ID: 32413824
[TBL] [Abstract][Full Text] [Related]
13. MALDI imaging mass spectrometry for in situ proteomic analysis of preneoplastic lesions in pancreatic cancer.
Grüner BM; Hahne H; Mazur PK; Trajkovic-Arsic M; Maier S; Esposito I; Kalideris E; Michalski CW; Kleeff J; Rauser S; Schmid RM; Küster B; Walch A; Siveke JT
PLoS One; 2012; 7(6):e39424. PubMed ID: 22761793
[TBL] [Abstract][Full Text] [Related]
14. Label-free proteomics reveals serum proteins whose levels differ between pancreatic ductal adenocarcinoma patients with short or long survival.
Holm M; Saraswat M; Joenväärä S; Seppänen H; Renkonen R; Haglund C
Tumour Biol; 2020 Jun; 42(6):1010428320936410. PubMed ID: 32586207
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of Stromal Type IV Collagen Expression in Small Invasive Breast Cancers.
Jansson M; Lindberg J; Rask G; Svensson J; Billing O; Nazemroaya A; Berglund A; Wärnberg F; Sund M
Front Mol Biosci; 2022; 9():904526. PubMed ID: 35693557
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]